PUBLISHER: The Business Research Company | PRODUCT CODE: 1938746
PUBLISHER: The Business Research Company | PRODUCT CODE: 1938746
Veterinary point-of-care diagnostics play a vital role in real-time animal health assessment, delivering clinically relevant information during clinical practice without relying on laboratory results. This approach significantly reduces the turnaround time (TAT) for animal test results, aiding clinicians in promptly determining the appropriate treatment course for their patients.
The primary products within veterinary point-of-care diagnostics include consumables, reagents, kits, instruments, and devices. Consumables, reagents, and kits are utilized in the diagnosis of infectious and metabolic diseases in both companion and livestock animals. These products encompass substances consumed during testing, materials for preparing diagnostic products, and test kits used in various diagnostic technologies such as immunodiagnostics, clinical biochemistry, molecular diagnostics, hematology, urinalysis, and other related technologies. Veterinary point-of-care diagnostics find application in veterinary clinics, hospitals, academic institutes, and even home care settings for the benefit of animal health.
Tariffs have impacted the veterinary point-of-care diagnostics market by increasing costs for imported instruments, reagents, and consumables, which has affected product pricing and supply timelines. Companion animal and livestock segments in regions like North America and Europe are most affected due to dependency on imported diagnostic kits and analyzers. Positive impacts include boosting domestic manufacturing and encouraging local innovation in cost-effective point-of-care solutions, helping reduce reliance on imports over time.
The veterinary point of care diagnostics market research report is one of a series of new reports from The Business Research Company that provides veterinary point of care diagnostics market statistics, including veterinary point of care diagnostics industry global market size, regional shares, competitors with a veterinary point of care diagnostics market share, detailed veterinary point of care diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary point of care diagnostics industry. This veterinary point of care diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The veterinary point of care diagnostics market size has grown rapidly in recent years. It will grow from $2.01 billion in 2025 to $2.28 billion in 2026 at a compound annual growth rate (CAGR) of 13.4%. The growth in the historic period can be attributed to rising prevalence of infectious and metabolic diseases in animals, growth of veterinary clinics and hospitals, increasing awareness of animal health, advancements in diagnostic reagents and kits, rising companion animal population.
The veterinary point of care diagnostics market size is expected to see rapid growth in the next few years. It will grow to $3.75 billion in 2030 at a compound annual growth rate (CAGR) of 13.3%. The growth in the forecast period can be attributed to adoption of portable diagnostic analyzers, integration of AI and IoT in veterinary diagnostics, growth in home care veterinary solutions, increasing investment in veterinary point-of-care R&D, expansion of molecular and biochemical diagnostic technologies. Major trends in the forecast period include increasing adoption of rapid diagnostic tools, rising demand for on-site testing solutions, expansion of companion animal health monitoring, integration of real-time data in veterinary care, growth of preventive veterinary diagnostics.
The rising companion animal population is expected to drive growth in the veterinary point-of-care diagnostics market in the coming years. Companion animals are pets that live in close proximity to humans. The increase in companion animal numbers is boosting demand for veterinary point-of-care diagnostics, which enable faster clinical decision-making in diagnosis, treatment selection, monitoring, prognosis, as well as operational and resource management. Veterinary point-of-care diagnostics support the companion animal population by providing rapid and accurate health assessments, allowing timely treatment and improved overall care. For example, in March 2025, according to the American Pet Products Association, a US-based national pet products trade organization, 94 million U.S. households owned at least one pet, up from 82 million in 2023, reflecting a significant rise in companion animal adoption. Therefore, the growing companion animal population is propelling the veterinary point-of-care diagnostics market.
Leading players in the veterinary point-of-care diagnostics market are developing innovative assays to maintain a competitive edge. Assays are diagnostic tests designed to detect specific biological markers, substances, or conditions associated with particular diseases. For instance, in September 2023, Zomedica Corp., a US-based veterinary health company, launched a new assay, endogenous ACTH (eACTH), for equine plasma on its TRUFORMA In-Clinic Biosensor Testing Platform. This assay allows equine veterinarians to diagnose and manage Cushing's Disease (pituitary pars intermedia dysfunction - PPID) conveniently at the clinic or stall. The eACTH assay provides reference-laboratory-level accuracy, supporting effective diagnosis and monitoring of horses with PPID, a common endocrine disorder in equines. Zomedica designed the TRUFORMA platform to meet the specific needs of equine practitioners, enhancing both patient care and practice efficiency.
In June 2023, Mars Incorporated, a US-based provider of pet nutrition, veterinary services, diagnostic solutions, and animal healthcare products, acquired Heska Corporation for $120.00 per share under a definitive agreement. Through this acquisition, Mars Petcare aimed to expand access to veterinary diagnostics and technology, accelerate R&D, and enhance its global point-of-care diagnostic capabilities within its Science & Diagnostics division, strengthening its position in the veterinary healthcare market. Heska Corporation is a US-based provider of veterinary point-of-care diagnostic instruments, in-clinic analyzers, consumables, and related software solutions for companion animal veterinarians.
Major companies operating in the veterinary point of care diagnostics market are IDEXX Laboratories Inc., Heska Corporation, Eurolyser Diagnostica GmbH, Anipoc Ltd., Alvedia, Bionote Inc., Mindray Bio-Medical Electronics Co. Ltd., Thermo Fisher Scientific Inc., BioGal Galed Labs, MEGACOR Diagnostik GmbH, GeneReach, Quidel Corporation, Biopanda Reagents Ltd., Biochek BV, IDvet, Skyla Corporation, Fassisi GmbH, GE Healthcare, Esaote SpA, BioMerieux SA, Prometheus Bio Inc., Midland BioProducts
North America was the largest region in the veterinary point of care diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary point of care diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the veterinary point of care diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The veterinary point-of-care diagnostics market includes revenues earned by entities by hematology, diagnostic imaging, bacteriology, virology, cytology, clinical chemistry and parasitology. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Veterinary Point Of Care Diagnostics Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses veterinary point of care diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for veterinary point of care diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The veterinary point of care diagnostics market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.